- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07939724
Observational Prospective Evaluation of Factors Affecting Hospitalisation in Patients Undergoing EBUS-TBNA
In this study, the perioperative data of EBUS procedures, file information, and anesthesia records during the procedure were analyzed in relation to patient complication rates and the correlation of complications with patient profiles
Study Overview
Status
Conditions
Detailed Description
Many noninvasive and invasive methods are used for the evaluation of mediastinal masses and lymph nodes. Mediastinoscopy is the gold standard for evaluation. However, this procedure is invasive and requires hospitalisation. In addition, mediastinoscopy has some life-threatening complications such as mediastinal surgical bleeding, mediastinitis, pneumothorax and subcutaneous emphysema. Therefore, different minimally invasive methods have been tried. Endobronchial ultrasound has been accepted as a reliable procedure frequently used in preoperative nodal staging because it has similar diagnostic values compared to mediastinoscopy, low complication rates and is a less invasive method.
In this study, patients were evaluated in a wide range of scales. Preoperative pulmonary function tests, STOP-BANG/Charlson Comorbidity Index questionnaire scores, preoperative blood gas values, additional comorbidities, ASA and Body mass indexes, saturation values before the procedure, saturation values during the procedure and complications occurring during the procedure are discussed. In the light of this information, the factors affecting the post-procedure hospitalisations of the patients were evaluated comprehensively. In addition, the duration of PACU/ICU requirement of these patients was also compared according to these criteria. In addition to ASA scores, 4 main specialised ASA scores were performed in the patients: Cardiovascular, Renal, Liver and Central Nervous System ASA.
According to the data mentioned, patients were divided into two groups: those discharged home after the procedure and those requiring hospital admission. During the preoperative anesthesia consultation, patients' postoperative needs were assessed according to PACU/ICU requirements as planned or unplanned PACU/ICU/ward admissions. Complication rates were compared based on the procedure areas according to the Wang Map. For these patients, the time to exitus within 1 month and between 1 and 6 months post-procedure was also evaluated.
Preoperative values, including hemogram, electrolytes, BUN, creatinine, ALT, AST, INR, and APTT, were reviewed for the patients. The relationship between these values and the need for hospital admission post-procedure was examined.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Antalya, Turkey (Türkiye), 07070
- Akdeniz University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Patients over 18 years of age who underwent EBUS
Description
Inclusion Criteria:
- Being over 18 years of age
Exclusion Criteria:
- Emergency operations, those whose data cannot be accessed, those whose transactions are canceled during the procedure
Study Plan
How is the study designed?
Design Details
- Observational Models: CASE_ONLY
- Time Perspectives: PROSPECTIVE
Cohorts and Interventions
Group / Cohort |
|---|
|
dischared patients
Patients discharged after ebus procedure |
|
Hospitalized patients
Patients who are admitted to the ward or PACU or ICU after the procedure |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hospitalization percentage
Time Frame: After the procedure
|
The percentage of patients admitted to the hospital ward, PACU (Post-Anesthesia Care Unit), or ICU (Intensive Care Unit). |
After the procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Complications
Time Frame: During or after the procedure
|
Postoperative complications such as desaturation, arrhythmia, minor bleeding, hypertansion, hypoxemia |
During or after the procedure
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.